Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer Letters|November 8, 2019
MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2Carina Seidl, Katrin Panzitt, Alexandra Bertsch, et al.
Cancers|August 27, 2021
MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent MechanismsFlorian Posch, Felix Prinz, Amar Balihodzic, et al.
Plos One|June 30, 2023
Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cellsChristian Mayr, Tobias Kiesslich, Dino Bekric, et al.
RNA Biology|December 5, 2022
MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon responseFelix Prinz, Katharina Jonas, Amar Balihodzic, et al.
Cancer Medicine|June 16, 2020
External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patientsDominik Andreas Barth, Carina Brenner, Jakob Michael Riedl, et al.
Cancers|July 9, 2020
The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic CancerMichael Stotz, Dominik A Barth, Jakob M Riedl, et al.
Cancers|May 8, 2020
Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer PatientsEva Valentina Klocker, Dominik Andreas Barth, Jakob Michael Riedl, et al.
Cancer Discovery|April 2, 2024
CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell PoolPaulien Kaptein, Nadine Slingerland, Christina Metoikidou, et al.
Scientific Reports|April 5, 2019
Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysisFlorian Moik, Jakob M Riedl, Thomas Winder, et al.
Cellular and Molecular Life Sciences : CMLS|July 1, 2022
ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoformChristiane Klec, Erik Knutsen, Daniela Schwarzenbacher, et al.
Pageof 2